已验证衰弱评分与住院COVID-19成人患者死亡率的关系:一项系统综述
22/26项研究使用临床衰弱量表(CFS),报告死亡率范围为14%至65%;多数但非全部研究显示衰弱程度增加与死亡风险升高相关,部分研究提示需更细致理解衰弱与COVID-19结局的关系。
要点
- 多数研究显示衰弱程度增加与COVID-19住院患者死亡风险升高相关。
- 22/26项研究使用临床衰弱量表(CFS),报告死亡率范围为14%至65%。
- 临床讨论老年COVID-19患者预后时,不宜过度强调衰弱单一因素。
核心结论
- 多数研究显示COVID-19相关死亡与衰弱程度增加呈正相关,但部分研究提示需要更细致理解衰弱与COVID-19结局的关系。
- 临床医生在讨论老年COVID-19患者可能预后时,应谨慎避免过度强调衰弱单一因素的影响。
研究设计与样本
- 由两名评价者进行筛选、数据提取和质量分级,共筛选2286篇文献,最终纳入26项研究。
- 纳入研究中位样本量242.5例,中位年龄73.1岁,43.5%为女性;多数研究来自欧洲,半数来自英国,一项来自巴西。
主要发现
- 22/26项研究使用临床衰弱量表(CFS),报告死亡率范围为14%至65%。
- 多数但非全部研究显示衰弱程度增加与死亡风险升高相关。
- 两项研究提示衰弱、COVID-19与死亡之间呈次可加关系,两项研究显示无关联。
关键数值与推荐
- 22/26项研究使用临床衰弱量表(CFS)评估衰弱。
- 报告死亡率范围为14%至65%。
临床怎么用
- 在老年COVID-19患者预后讨论中,可参考衰弱评估结果,但不应仅凭衰弱程度推断预后。
- 对衰弱程度较高的COVID-19住院患者,应结合其他临床因素综合判断死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIM: The aim of this systematic review was to quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients. METHODS: Medline, Embase, Web of Science and the grey literature were searched for papers from inception to 10 September 2020; the search was re-run in Medline up until the 9 December 2020. Screening, data extraction and quality grading were undertaken by two reviewers. Results were summarised using descriptive statistics, including a meta-analysis of overall mortality; the relationships between frailty and COVID-19 mortality were summarised narratively. RESULTS: A total of 2,286 papers were screened resulting in 26 being included in the review. Most studies were from Europe, half from the UK, and one from Brazil; the median sample size was 242.5, median age 73.1 and 43.5% were female. In total, 22/26 used the Clinical Frailty Scale; reported mortality ranged from 14 to 65%. Most, but not all studies showed an association between increasing frailty and a greater risk of dying. Two studies indicated a sub-additive relationship between frailty, COVID-19 and death, and two studies showed no association. CONCLUSIONS: Whilst the majority of studies have shown a positive association between COVID-19-related death and increasing frailty, some studies suggested a more nuanced understanding of frailty and outcomes in COVID-19 is needed. Clinicians should exert caution in placing too much emphasis on the influence of frailty alone when discussing likely prognosis in older people with COVID-19 illness.
引用
- Cosco TD, Best J, Davis D, et al. What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review. Age Ageing. 2021. PMID: 33951151. doi:10.1093/ageing/afab008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。